Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis

Cancer Letters

Volumn 271, Issue 2, 2008, Pages 306-313

  Rho, Seung Bae ^b   Byun, Hyun Jung ^a   Park, Sang Yoon ^b   Chun, Taehoon ^a  

^a Korea University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Angiogenesis; Apoptosis; Calpain 6; Endothelial cell; Ovarian carcinoma cell

Indexed keywords

CALPAIN; CALPAIN 6; CISPLATIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CALPAIN; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; HELA CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 53449095522     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.020     Document Type: Article

References (28)

1. Demarchi F., and Schneider C. The calpain system as a modulator of stress/damage response. Cell Cycle 6 (2007) 136-138
2. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
3. Carafoli E., and Molinari M. Calpain: a protease in search of function?. Biochem. Biophys. Res. Commun. 247 (1998) 193-203
4. Franco S.J., and Huttenlocher A. Regulating cell migration: calpains make the cut. J. Cell Sci. 118 (2005) 3829-3838
5. Tan Y., Wu C., De Veyra T., and Greer P.A. Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J. Biol. Chem. 281 (2003) 17689-17698
6. Dear N., Matena K., Vingron M., and Boehm T. A new subfamily of vertebrate calpains lacking a calmodulin-like domain: implications for calpain regulation and evolution. Genomics 45 (1997) 175-184
7. Dear N., and Boehm T. Diverse mRNA expression patterns of the mouse calpain genes Capn5, CAPN6 and Capn11 during development. Mech. Dev. 89 (1999) 201-209
8. Skubitz K.M., and Skubitz A.P. Differential gene expression in leiomyosarcoma. Cancer 98 (2003) 1029-1038
9. Skubitz K.M., and Skubitz A.P. Differential gene expression in uterine leiomyoma. J. Lab. Clin. Med. 141 (2003) 297-308
10. Lee S.J., Cho Y.L., Lee E.J., Kim B.G., Bae D.S., Ahn G.H., and Lee J.H. Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis. Int. J. Gynecol. Cancer 17 (2007) 248-253
11. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
12. Lee O.H., Kim Y.M., Lee Y.M., Moon E.J., Lee D.J., Kim J.H., Kim K.W., and Kwon Y.G. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 264 (1999) 743-750
13. Wesierska-Gadek J., Schloffer D., Kotala V., and Horky M. Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int. J. Cancer 101 (2002) 128-136
14. Mistry P., Kelland L.R., Abel G., Sidhar S., and Harrap K.R. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br. J. Cancer 64 (1991) 215-220
15. Funaoka K., Shindoh M., Yamashita T., Fujinaga K., Amemiya A., and Totsuka Y. High-risk HPV-positive human cancer cell lines show different sensitivity to cisplatin-induced apoptosis correlated with the p21Waf1/Cip1 level. Cancer Lett. 108 (1996) 15-23
16. Blanc C., Deveraux Q.L., Krajewski S., Jänicke R.U., Porter A.G., Reed J.C., Jaggi R., and Marti A. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 Breast Cancer Cells. Cancer Res. 60 (2000) 4386-4390
17. Ray S.K., Wilford G.G., Crosby C.V., Hogan E.L., and Banik N.L. Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res. 829 (1999) 18-27
18. 2+ influx upregulate calpain and induce apoptosis in PC12 cells. Brain Res. 852 (2000) 326-334
19. Mellgren R.L., and Lane R.D. Myocardial calpain 2 is inhibited by monoclonal antibodies specific for the small, noncatalytic subunit. Biochim. Biophys. Acta 954 (1988) 154-160
20. Mellor G.W., Sreedharan S.K., Kowlessur D., Thomas E.W., and Brocklehurst K. Catalytic-site characteristics of the porcine calpain II 80 kDa/18 kDa heterodimer revealed by selective reaction of its essential thiol group with two-hydronic-state time-dependent inhibitors: evidence for a catalytic site Cys/His interactive system and an ionizing modulatory group. Biochem. J. 290 (1993) 75-83
21. Kitagaki H., Tomioka S., Yoshizawa T., Sorimachi H., Saido T.C., Ishiura S., and Suzuki K. Autolysis of calpain large subunit inducing irreversible dissociation of stoichiometric heterodimer of calpain. Biosci. Biotechnol. Biochem. 64 (2000) 689-695
22. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
23. Risau W W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
24. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
25. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2 (2002) 795-803
26. Tonami K., Kurihara Y., Aburatani H., Uchijima Y., Asano T., and Kurihara H. Calpain 6 is involved in microtubule stabilization and cytoskeletal organization. Mol. Cell. Biol. 27 (2007) 2548-2561
27. Van Trappen P.O., Ryan A., Carroll M., Lecoeur C., Goff L., Gyselman V.G., Young B.D., Lowe D.G., Pepper M.S., Shepherd J.H., and Jacobs I.J. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br. J. Cancer 87 (2002) 537-544
28. Patton A.M., Kassis J., Doong H., and Kohn E.C. Calcium as a molecular target in angiogenesis. Curr. Pharm. Des. 9 (2003) 543-551